首页
400-620-6333
Notch
选项
-
Rovalpituzumab (anti-DLL3)关联靶标: DLL3简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1613313-01-1
-
Brontictuzumab (anti-NOTCH1)关联靶标: NOTCH1简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse) 亚型: Human IgG2SA宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1447814-75-6
-
Tarextumab (anti-NOTCH3)简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse) 亚型: Human IgG2宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1359940-55-8
-
Demcizumab (anti-DLL4)关联靶标: DLL4简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse) 亚型: Human IgG2SA宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1243262-17-0
-
Navicixizumab (anti-DLL4)关联靶标: DLL4简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG2SA宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1638338-43-8
-
Enoticumab (anti-DLL4)关联靶标: DLL4简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1192578-27-0
-
Tarlatamab (anti-DLL3&CD3)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1偶联: UnconjugatedCAS号: 2307488-83-9SMILES: [Tarlatamab]
